In addition, increased production of IL-5 and IL-10, and a reduction of tumor necrosis factor alpha (TNF-α), were identified in RR-MS patients, correlating with the RMN lesion and suggesting direct estriol anti-inflammatory effects in the brain [15]. This evidence concerns the gene IL10 and myeloid sarcoma.